Table 1: Demographic and Clinical Characteristics - Obj_1_AF_vs_general_population for positivecovidtest
	Total	0	1

1	  563,123 (100.0)	  511,375 (100.0)	   51,748 (100.0)

Grouped age
1	    1,373 (0.2)	    1,247 (0.2)	      126 (0.2)
2	    8,242 (1.5)	    7,490 (1.5)	      752 (1.5)
3	   50,692 (9.0)	   46,059 (9.0)	    4,633 (9.0)
4	  171,482 (30.5)	  155,830 (30.5)	   15,652 (30.2)
5	  246,421 (43.8)	  223,943 (43.8)	   22,478 (43.4)
6	   84,913 (15.1)	   76,806 (15.0)	    8,107 (15.7)

Male
0	  118,188 (21.0)	  107,387 (21.0)	   10,801 (20.9)
1	  444,935 (79.0)	  403,988 (79.0)	   40,947 (79.1)

Grouped BMI
1	    5,642 (1.0)	    5,149 (1.0)	      493 (1.0)
2	  144,048 (25.6)	  132,425 (25.9)	   11,623 (22.5)
3	  216,134 (38.4)	  198,462 (38.8)	   17,672 (34.2)
4	  106,545 (18.9)	   95,560 (18.7)	   10,985 (21.2)
5	   33,959 (6.0)	   29,252 (5.7)	    4,707 (9.1)
6	   13,971 (2.5)	   11,118 (2.2)	    2,853 (5.5)
.	   42,824 (7.6)	   39,409 (7.7)	    3,415 (6.6)

Smoking status
1	  201,908 (35.9)	  183,143 (35.8)	   18,765 (36.3)
2	  302,228 (53.7)	  273,179 (53.4)	   29,049 (56.1)
3	   57,706 (10.2)	   53,861 (10.5)	    3,845 (7.4)
.	    1,281 (0.2)	    1,192 (0.2)	       89 (0.2)

Ethnicity
1	  410,220 (72.8)	  372,812 (72.9)	   37,408 (72.3)
2	    1,705 (0.3)	    1,603 (0.3)	      102 (0.2)
3	   11,558 (2.1)	   11,055 (2.2)	      503 (1.0)
4	    4,077 (0.7)	    3,894 (0.8)	      183 (0.4)
5	    3,238 (0.6)	    3,023 (0.6)	      215 (0.4)
.	  132,325 (23.5)	  118,988 (23.3)	   13,337 (25.8)

Index of Multiple Deprivation (IMD)
1	  113,616 (20.2)	  102,382 (20.0)	   11,234 (21.7)
2	  114,367 (20.3)	  103,627 (20.3)	   10,740 (20.8)
3	  112,785 (20.0)	  102,249 (20.0)	   10,536 (20.4)
4	  111,243 (19.8)	  101,426 (19.8)	    9,817 (19.0)
5	  111,112 (19.7)	  101,691 (19.9)	    9,421 (18.2)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Diabetes Severity
1	  446,415 (79.3)	  401,003 (78.4)	   45,412 (87.8)
2	   80,815 (14.4)	   76,616 (15.0)	    4,199 (8.1)
3	   34,560 (6.1)	   32,493 (6.4)	    2,067 (4.0)
4	    1,333 (0.2)	    1,263 (0.2)	       70 (0.1)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Diagnosed hypertension
1	  271,317 (48.2)	  249,719 (48.8)	   21,598 (41.7)
Heart Failure
1	   21,080 (3.7)	   15,521 (3.0)	    5,559 (10.7)
Diabetes
1	  116,708 (20.7)	  110,372 (21.6)	    6,336 (12.2)
COPD
1	   49,579 (8.8)	   44,437 (8.7)	    5,142 (9.9)
Other Respiratory Diseases
1	   18,747 (3.3)	   16,666 (3.3)	    2,081 (4.0)
Cancer
1	   78,234 (13.9)	   70,414 (13.8)	    7,820 (15.1)
Immunosuppressed (combination algorithm)
1	    3,941 (0.7)	    3,507 (0.7)	      434 (0.8)
Chronic kidney disease
1	   73,693 (13.1)	   65,405 (12.8)	    8,288 (16.0)
Flu vaccine
1	  375,089 (66.6)	  336,008 (65.7)	   39,081 (75.5)
Recent Oestrogen
1	    4,665 (0.8)	    4,314 (0.8)	      351 (0.7)
Recent antiplatelet
1	  107,762 (19.1)	  105,504 (20.6)	    2,258 (4.4)
Myocardial infarction
1	   33,969 (6.0)	   32,374 (6.3)	    1,595 (3.1)
Peripheral arterial disease
1	   14,808 (2.6)	   14,389 (2.8)	      419 (0.8)
Stroke/Transient ischaemic attack
1	   37,210 (6.6)	   36,189 (7.1)	    1,021 (2.0)
Venous thromboembolism
1	   13,459 (2.4)	   12,916 (2.5)	      543 (1.0)


GP consultation count
Median (IQR)	6 (3-11)	6 (3-11)	10 (5-17)
Min, Max	0, 386	1, 386	0, 198
Age (years)
Median (IQR)	71 (66-75)	71 (66-75)	71 (66-75)
Min, Max	18, 101	18, 101	18, 100
A&E attendance count
Median (IQR)	0 (0-0)	0 (0-0)	0 (0-1)
Min, Max	0, 71	0, 71	0, 54
